NICE has published a new draft guideline for polyendocrine metabolic ovarian syndrome (PMOS), setting out recommendations aimed at helping people receive a diagnosis sooner and regular follow-up care to monitor symptoms, treatment and longer-term health risks. The draft was published for public consultation on 1 July 2026, and NICE says feedback from healthcare professionals, patients and the public will be accepted until 11 August 2026. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
A push for earlier recognition of a complex condition
According to NICE, the draft guideline is designed to improve both diagnosis and ongoing management of PMOS, a condition that can affect multiple aspects of health. The recommendation for an annual review is intended to give clinicians a structured way to track symptoms and review the impact of treatment over time. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
The consultation marks an early step in shaping future care for patients, with NICE inviting input before final guidance is issued. That process is meant to ensure the recommendations reflect clinical practice as well as the experience of people living with the condition. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
What the draft guidance could mean for NHS care
If adopted, the draft would encourage a more consistent approach to identifying PMOS and following patients after diagnosis. NICE says annual reviews should help monitor symptoms, treatment and long-term health risks, which could support earlier intervention when problems develop. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
The consultation window runs from 1 July to 11 August 2026, giving stakeholders several weeks to comment on the proposal before any final version is published. For patients and clinicians, the draft offers a chance to influence how the NHS approaches a condition where clearer pathways may improve continuity of care. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
A wider pattern of UK guidance updates
The draft PMOS document arrives amid a busy period for NICE, which has also recently updated or reviewed other clinical guidance across different specialties. That includes ongoing work on pathways, treatment options and monitoring recommendations intended to keep NHS care aligned with newer evidence and evolving practice. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
For now, the PMOS proposal remains open to consultation, but its focus is clear: faster diagnosis, regular review and more structured support for patients who may otherwise wait longer for recognition and care. ([nice.org.uk](https://www.nice.org.uk/news/articles/nice-recommends-annual-review-for-pmos-in-new-draft-guideline-aimed-at-improving-diagnosis-and-care?utm_source=openai))
